Europe

Local Covid vaccines fill gap as UN Covax scheme misses target

India, Egypt and Cuba among first states to develop and make their own vaccines as Covax falls behind Developing countries are increasingly turning to homegrown Covid vaccinations as the UN-backed Covax programme falls behind. While western countries roll out booster jabs to their own populations, Covax, which was set up by UN agencies, governments and …

Local Covid vaccines fill gap as UN Covax scheme misses target Read More »

How Is It Possible That Mammograms Don’t Actually Save Lives?

For every life saved by mammography, as many as two to ten women are overdiagnosed and unnecessarily turned into breast cancer patients with all of the attendant harms of chemo, radiation, or surgery, without the benefits. What was the impact of the 2009 shift in recommendations by the U.S. Preventive Services Task Force (USPSTF) to …

How Is It Possible That Mammograms Don’t Actually Save Lives? Read More »

Coronavirus treatments: the potential ‘game-changers’ in development

After positive clinical trials for antiviral drug Molnupiravir, it joins other medicines that have shown promise Coronavirus – latest updates See all our coronavirus coverage The first clinical trial results showing a positive effect for a pill that can be taken at home has been hailed as a potential gamechanger that could provide a new …

Coronavirus treatments: the potential ‘game-changers’ in development Read More »

Digital health in Europe: Before and after COVID

An interesting report from the European Observatory on Health Systems and Policies examined the “Use of digital health tools in Europe: before, during and after COVID-19“. Digital health is important not only because the technologies facilitate communication and disease monitoring, but also the technologies facilitate the creation of data that can be used to better …

Digital health in Europe: Before and after COVID Read More »

Ministers told to bar EU from UK trial data in vaccines row

England’s deputy medical chief asked for data to be withheld unless British vaccine guinea pigs allowed to travel abroad • Coronavirus – latest updates• See all our coronavirus coverage England’s deputy chief medical officer asked ministers to withhold all UK clinical trial data from the EU if European countries continued to deny entry to British …

Ministers told to bar EU from UK trial data in vaccines row Read More »

UK cancels Covid vaccine deal with French firm Valneva

Government serves notice to terminate contract over allegations of a ‘breach of obligations’ Coronavirus – latest updates See all our coronavirus coverage The UK government is to pull out of a deal with the French pharmaceutical company Valneva to purchase its Covid-19 vaccination, the company has said. The move will come as a blow to …

UK cancels Covid vaccine deal with French firm Valneva Read More »

BioNTech to seek approval for Covid jabs for younger children

Company behind Pfizer vaccine expected to file results of trial of five- to 11-year-olds with regulator soon Coronavirus – latest updates See all our coronavirus coverage The German company BioNTech, which developed the Pfizer vaccine, expects to seek approval from regulators for Covid jabs suited for younger children as early as mid-October, its founders have …

BioNTech to seek approval for Covid jabs for younger children Read More »

UK could allow animal tests for cosmetic ingredients for first time since 1998

Exclusive: campaigners say aligning with EU ruling on chemical testing will ‘blow a hole’ in UK leadership on cruelty-free cosmetics Ministers have opened the door to expanding the use of animal testing to ingredients used in cosmetic products for the first time in 23 years, an animal welfare charity has said. Cruelty Free International (CFI) …

UK could allow animal tests for cosmetic ingredients for first time since 1998 Read More »

Gene therapy specialist bluebird exits “untenable” European market

Europe market has proved so hostile to gene therapies when it comes to pricing and reimbursement for gene therapies that bluebird bio has decided to quit the market altogether, according to Andrew Obenshain, president of its severe genetic diseases unit. On the firm’s second-quarter results call, Obenshain said the biotech will start “an orderly wind-down” …

Gene therapy specialist bluebird exits “untenable” European market Read More »

Almirall and Kaken Enter into a License Agreement for the Development and Commercialization of Efinaconazole in Europe

Shots: Kaken to receive an up front in cash and is eligible to receive milestones and royalties on the sales of the product. Almirall plans to have a pre-submission meeting with regulatory authorities in next year to prepare the approval of the product in the EU Almirall get the exclusive rights for the development and …

Almirall and Kaken Enter into a License Agreement for the Development and Commercialization of Efinaconazole in Europe Read More »

How easy is it for patients to access cell and gene therapies in Europe?

Cell and gene therapies have the potential to produce dramatic improvements in quality of life and survival for severe and often rare diseases. Currently, however, the cost of these treatments is high and access is sometimes limited. To identify some of these challenges in Europe EURODIS conducted an evaluation of country-specific challenges with respect to …

How easy is it for patients to access cell and gene therapies in Europe? Read More »

EU fails in court action to secure urgent 120m doses of Oxford Covid vaccine

But Brussels court says AstraZeneca should earlier have used UK plants to fulfil EU deliveries Coronavirus – latest updates See all our coronavirus coverage The EU has failed in a legal attempt to secure an urgent 120m vaccine doses from AstraZeneca by the end of this month, while securing a judgment that sites in Oxford …

EU fails in court action to secure urgent 120m doses of Oxford Covid vaccine Read More »

EU fails in court action to secure urgent 120m doses of Oxford Covid vaccine

But Brussels court says AstraZeneca should earlier have used UK plants to fulfil EU deliveries Coronavirus – latest updates See all our coronavirus coverage The EU has failed in a legal attempt to secure an urgent 120m vaccine doses from AstraZeneca by the end of this month, while securing a judgment that sites in Oxford …

EU fails in court action to secure urgent 120m doses of Oxford Covid vaccine Read More »

From representation to empowerment: Putting patients at the centre of medicine reimbursement

Experts from Vynamic discuss their vision for a future where patients are at the heart of medicine reimbursement in Europe – and provide actionable steps for achieving this. This article appears in full in our digital magazine Deep Dive: Market Access 2021. Read below for a sneak-peak: The reimbursement landscape in Europe is complex. There …

From representation to empowerment: Putting patients at the centre of medicine reimbursement Read More »

Baltimore Vaccine Plant’s Troubles Ripple Across Africa, Europe and Canada

Millions of doses of Johnson & Johnson’s Covid-19 vaccine produced by Emergent BioSolutions have been held back in Europe, South Africa and Canada as a precaution.

EU wants to mass produce three ‘course-changing’ Covid drugs from October

Health commissioner says plan is to reduce hospitalisation and tackle long-term impact of Covid Coronavirus – latest updates See all our coronavirus coverage Three Covid medicines with the potential to “change the course” of the pandemic will be authorised for mass production and use in the EU by October under a European Commission plan. Stella …

EU wants to mass produce three ‘course-changing’ Covid drugs from October Read More »

EU ‘ready to discuss’ waiver on Covid vaccine patents

Emmanuel Macron also supports US-backed proposal described as a gamechanger by WHO Coronavirus – latest updates See all our coronavirus coverage The head of the European commission, Ursula von der Leyen, has said the bloc is “ready to discuss” a US-backed proposal for a waiver on the patents for Covid-19 vaccines and the French president, …

EU ‘ready to discuss’ waiver on Covid vaccine patents Read More »

Pfizer forecasts $26bn from annual sales of Covid-19 vaccine

Vaccine will generate 73% more than forecast based on contracts signed until mid-April Coronavirus – latest updates See all our coronavirus coverage US drugmaker Pfizer expects to make $26bn (£19bn) in revenues from sales of its Covid-19 vaccine this year, with its soaraway product accounting for more than a third of the company’s annual income. …

Pfizer forecasts $26bn from annual sales of Covid-19 vaccine Read More »

AstraZeneca revenues up as it delivers jab to 120 countries via Covax

Quarterly results from Anglo-Swedish producer of Covid vaccine show better-than-expected 15% rise Coronavirus – latest updates See all our coronavirus coverage AstraZeneca has generated $275m (£197m) in revenues from its Covid vaccine in the first three months of the year and shipped 48m doses to 120 countries through the global vaccine-sharing initiative Covax. Most of …

AstraZeneca revenues up as it delivers jab to 120 countries via Covax Read More »

Abbott Launches AI-Powered Coronary Imaging Platform in Europe

Shots: Abbott’s new imaging platform powered by Ultreon 1.0 software has received a CE mark in the EU. The new imaging platform merges optical coherence tomography (OCT) with AI to enhance visualization and detect the severity of calcium-based blockages and measure vessel diameter Ultreon software when integrated with Abbott’s new Dragonfly OpStar imaging catheter allows …

Abbott Launches AI-Powered Coronary Imaging Platform in Europe Read More »

EU starts legal action against AstraZeneca over vaccine shortfalls

Firm says it will ‘strongly defend itself’ against claim it breached agreement to supply Covid jab Coronavirus – latest updates See all our coronavirus coverage AstraZeneca said it would “strongly defend itself in court” and highlighted its supply of 50m Covid vaccine doses to European countries as Brussels launched legal action against the pharmaceutical company …

EU starts legal action against AstraZeneca over vaccine shortfalls Read More »

GSK’s Jemperli (dostarlimab) Receives the EC’s Approval for Recurrent or Advanced dMMR/MSI-H Endometrial Cancer

Shots: The EC has granted conditional approval for Jemperli in women with dMMR/ MSI-H endometrial cancer that has progressed on or following prior treatment with a Pt.- containing regimen AnaptysBio has received $10M as milestones upon the EC’s approval and will receive $35M as regulatory milestones in the US & EU, $165M as sales milestones …

GSK’s Jemperli (dostarlimab) Receives the EC’s Approval for Recurrent or Advanced dMMR/MSI-H Endometrial Cancer Read More »

EU asks states to back legal action against AstraZeneca

Commission move causes concern about bringing case against key supplier of Covid vaccines Coronavirus – latest updates See all our coronavirus coverage EU capitals have been asked by the European commission to back legal action against AstraZeneca by the end of the week over an alleged breach of its contractual obligations to supply member states …

EU asks states to back legal action against AstraZeneca Read More »

Medtronic Launches World’s First Extended Insulin Infusion Set to Reduce Burden for People with Diabetes in Europe

Shots: Medtronic launches a new insulin infusion set that can be worn for up to 7days. The infusion set is compatible with all MiniMed 600 and 700 series insulin pumps The extended infusion set utilizes advanced materials that help in reducing insulin preservative loss and maintains its flow & stability. The new tubing connector improves …

Medtronic Launches World’s First Extended Insulin Infusion Set to Reduce Burden for People with Diabetes in Europe Read More »

EU seeking ‘urgent clarification’ on Johnson & Johnson Covid vaccine delay

Company has said it is postponing deployment in Europe following concerns about blood clots in US Coronavirus – latest updates See all our coronavirus coverage The European commission is seeking “urgent clarification” from Johnson & Johnson after the company’s “completely unexpected” announcement that it has decided to delay the deployment of its coronavirus vaccine across …

EU seeking ‘urgent clarification’ on Johnson & Johnson Covid vaccine delay Read More »

EU agency examines reports of blood clots with J&J Covid vaccine

EMA says four serious cases reported, one fatal, and also expands inquiry into AstraZeneca vaccine Coronavirus – latest updates See all our coronavirus coverage The EU’s drug regulator is reviewing reports of rare blood clots in four people who received Johnson & Johnson’s Covid-19 vaccine and has expanded its inquiry into AstraZeneca’s shot to include …

EU agency examines reports of blood clots with J&J Covid vaccine Read More »

UK ministers silent on AstraZeneca vaccine shipment to Australia

Downing Street will not confirm or deny report that more than 700,000 Covid jabs were sent after EU blocked export Coronavirus – latest updates See all our coronavirus coverage British ministers and officials did not deny that more than 700,000 shots of the AstraZeneca vaccine were secretly dispatched from the UK to Australia a few …

UK ministers silent on AstraZeneca vaccine shipment to Australia Read More »

EU blames AstraZeneca ‘failure’ for sluggish Covid vaccine rollout

Anglo-Swedish company ‘solely’ to blame, says EU commissioner as bloc misses April vaccination target AstraZeneca has been squarely blamed by the EU for its comparatively slow Covid vaccine rollout after the bloc of 27 states failed to achieve its target to vaccinate 80% of older people by the end of March. Thierry Breton, the EU …

EU blames AstraZeneca ‘failure’ for sluggish Covid vaccine rollout Read More »

Why Supply Isn’t the Only Thing Stymying Europe’s Coronavirus Vaccine Rollout

Bureaucratic inertia, a diffusion of responsibility and logistical problems have seriously undercut vaccination efforts. In Italy, it’s the older population that bears the brunt.

Why Supply Isn’t the Only Thing Stymying Europe’s Coronavirus Vaccine Rollout

Bureaucratic inertia, a diffusion of responsibility and logistical problems have seriously undercut vaccination efforts. In Italy, it’s the older population that bears the brunt.

Supply Isn’t the Only Thing Stymying Europe’s Vaccine Rollout

Bureaucratic inertia, a diffusion of responsibility and logistical problems have seriously undercut vaccination efforts. In Italy, it’s the older population that bears the brunt.

AstraZeneca dismisses claim 29m vaccine doses in Italy were bound for UK

Batches were found when Italian police searched factory at request of European commission Coronavirus – latest updates See all our coronavirus coverage AstraZeneca has dismissed as “inaccurate” a report in the Italian press that 29m doses of its Covid-19 vaccine found in factory near Rome were destined for the UK. La Stampa reported on Wednesday …

AstraZeneca dismisses claim 29m vaccine doses in Italy were bound for UK Read More »

EU to widen criteria for possible Covid vaccine export bans

Bloc expected to assess countries’ Covid vaccination coverage and record in facilitating exports to EU Coronavirus – latest updates See all our coronavirus coverage The EU is expected to take into account the level of vaccination coverage in a country and its record in facilitating exports to the bloc when deciding on whether to prohibit …

EU to widen criteria for possible Covid vaccine export bans Read More »

Boris Johnson: vaccine cooperation vital to help combat third Covid wave

PM stresses need to work with EU and says surge in infections is likely to ‘wash up on our shores’ Coronavirus – latest updates See all our coronavirus coverage Boris Johnson has urged international cooperation over vaccines, saying a third wave of coronavirus elsewhere in Europe would inevitably affect the UK. The prime minister’s remarks …

Boris Johnson: vaccine cooperation vital to help combat third Covid wave Read More »

Vaccine wars: the week that rocked the UK’s Covid jab rollout

After a week of bans, U-turns and warnings of supply shortfalls, public confidence in vaccination has been dented. Can Britain get back on the fast track out of lockdown? Coronavirus – latest updates See all our coronavirus coverage For Stacey Harris, the hardest part of organising vaccinations over the last couple of months has been …

Vaccine wars: the week that rocked the UK’s Covid jab rollout Read More »

France limits AstraZeneca Covid jab to over-55s as Europe treads cautiously

Three Scandinavian countries reserve judgment one day after EMA says shot is safe and effective Coronavirus – latest updates See all our coronavirus coverage France has said only people aged 55 and over should receive the AstraZeneca Covid-19 vaccine, and three Scandinavian countries have reserved judgment until next week, a day after Europe’s health regulator …

France limits AstraZeneca Covid jab to over-55s as Europe treads cautiously Read More »

France limits AstraZeneca Covid jab to over-55s as Europe treads cautiously

Three Scandinavian countries reserve judgment one day after EMA says shot is safe and effective Coronavirus – latest updates See all our coronavirus coverage France has said only people aged 55 and over should receive the AstraZeneca Covid-19 vaccine, and three Scandinavian countries have reserved judgment until next week, a day after Europe’s health regulator …

France limits AstraZeneca Covid jab to over-55s as Europe treads cautiously Read More »

The EU’s AstraZeneca vaccine stance will cost lives, here in Spain and all over Europe

Pooling the European Covid vaccine effort was a noble idea. In practice, it has been a disaster In the race between vaccines and new Covid-19 variants, I am on the losing team. There is a simple reason for this, and it is because I live in the European Union – in my case, in Spain. …

The EU’s AstraZeneca vaccine stance will cost lives, here in Spain and all over Europe Read More »

The EU’s AstraZeneca vaccine stance will cost lives, here in Spain and all over Europe

Pooling the European Covid vaccine effort was a noble idea. In practice, it has been a disaster In the race between vaccines and new Covid-19 variants, I am on the losing team. There is a simple reason for this, and it is because I live in the European Union – in my case, in Spain. …

The EU’s AstraZeneca vaccine stance will cost lives, here in Spain and all over Europe Read More »

European countries to resume AstraZeneca jabs after safety backing

EMA says benefits outweigh risks but it is continuing to study possible link with very rare blood clotting disorder Coronavirus – latest updates See all our coronavirus coverage Italy, France, Germany and several other countries will resume administering AstraZeneca jabs from Friday after Europe’s medicines regulator said the vaccine was “safe and effective” and its …

European countries to resume AstraZeneca jabs after safety backing Read More »

European countries to resume AstraZeneca jabs after safety backing

EMA says benefits outweigh risks but it is continuing to study possible link with very rare blood clotting disorder Coronavirus – latest updates See all our coronavirus coverage Italy, France, Germany and several other countries will resume administering AstraZeneca jabs from Friday after Europe’s medicines regulator said the vaccine was “safe and effective” and its …

European countries to resume AstraZeneca jabs after safety backing Read More »

AstraZeneca vaccine ‘safe and effective’, says European Medicines Agency – video

The Oxford/AstraZeneca coronavirus vaccine is ‘safe and effective’ and its benefits outweigh the risks, Europe’s medicines regulator has said. The director of the European Medicines Agency, Emer Cooke, said the agency’s safety committee had reached ‘a clear scientific conclusion’ and had not found that the vaccine was associated with an increase in the overall risk of …

AstraZeneca vaccine ‘safe and effective’, says European Medicines Agency – video Read More »

AstraZeneca vaccine ‘safe and effective’, says European Medicines Agency – video

The Oxford/AstraZeneca coronavirus vaccine is ‘safe and effective’ and its benefits outweigh the risks, Europe’s medicines regulator has said. The director of the European Medicines Agency, Emer Cooke, said the agency’s safety committee had reached ‘a clear scientific conclusion’ and had not found that the vaccine was associated with an increase in the overall risk of …

AstraZeneca vaccine ‘safe and effective’, says European Medicines Agency – video Read More »

EU to send formal letter to AstraZeneca in Covid vaccine dispute

Bloc hopes to resolve row as it emerges big member states back threat to halt jab exports Coronavirus – latest updates See all our coronavirus coverage The EU is to send a formal letter to AstraZeneca in an attempt to resolve its dispute over vaccine supplies, a spokesperson has said, as it emerged that capitals …

EU to send formal letter to AstraZeneca in Covid vaccine dispute Read More »

EU to send formal letter to AstraZeneca in Covid vaccine dispute

Bloc hopes to resolve row as it emerges big member states back threat to halt jab exports Coronavirus – latest updates See all our coronavirus coverage The EU is to send a formal letter to AstraZeneca in an attempt to resolve its dispute over vaccine supplies, a spokesperson has said, as it emerged that capitals …

EU to send formal letter to AstraZeneca in Covid vaccine dispute Read More »

Benefits of Oxford/AstraZeneca vaccine outweigh any risk, says EMA

European agency seeks to allay blood clot fears as Germany, France and Italy temporarily suspend use Coronavirus – latest updates See all our coronavirus coverage Europe’s medicines regulator has moved to stifle spiralling concern about the Oxford/AstraZeneca vaccine, saying the shot’s benefits outweigh the risks after four major EU countries announced they were suspending its …

Benefits of Oxford/AstraZeneca vaccine outweigh any risk, says EMA Read More »

ViewPoints Interview: ViiV Healthcare’s Max Laitaillade Shares Insight on Rukobia

In an interview with PharmaShots, Max Laitaillade, Vice President, Head of Global Research Strategy, ViiV Healthcare shared his views on the development of Rukobia and the story of its development. He also shed light on what this approval means to the patients. Shots: MA for Rukobia marks a critical breakthrough for this select group of …

ViewPoints Interview: ViiV Healthcare’s Max Laitaillade Shares Insight on Rukobia Read More »

Ireland suspends AstraZeneca Covid vaccine over blood clot concerns

Deployment of Oxford vaccine temporarily deferred after latest reports from Norway Coronavirus – latest updates See all our coronavirus coverage Ireland is suspending use of the Oxford/AstraZeneca vaccine against Covid as a precautionary measure following further reports of blood clots in people who have received it, this time from Norway. The deputy chief medical officer, …

Ireland suspends AstraZeneca Covid vaccine over blood clot concerns Read More »

Denmark pauses use of AstraZeneca vaccine to investigate blood clot reports

Health agency suspends use of Covid jab but says no conclusive link has been established Coronavirus – latest updates See all our coronavirus coverage Denmark’s national health agency has said it is temporarily suspending inoculations with the AstraZeneca vaccine after blood clots formed in several people who had the jab, one of whom has reportedly …

Denmark pauses use of AstraZeneca vaccine to investigate blood clot reports Read More »

Australia requests review of Italy’s block of vaccine export

Italian government said the 250,000 doses of AstraZeneca vaccine must be kept in EU Coronavirus – latest updates See all our coronavirus coverage Australia has asked for a review of Italy’s decision to block the export of 250,000 doses of the AstraZeneca vaccine to its shores. In the first such intervention under the EU’s controversial …

Australia requests review of Italy’s block of vaccine export Read More »

Italy blocks export of 250,000 AstraZeneca vaccine doses to Australia

Row continues between EU and drug firm after shortfall in vaccine deliveries to bloc Coronavirus – latest updates See all our coronavirus coverage Italy has blocked the export of 250,000 doses of the Oxford/AstraZeneca vaccine to Australia in an escalation of a row with the Anglo-Swedish company. In the first such intervention under the EU’s …

Italy blocks export of 250,000 AstraZeneca vaccine doses to Australia Read More »

Covid: Germany and France under pressure to shift Oxford vaccine

Both countries urged to take action to avoid pile-up of unused AstraZeneca vaccine doses Coronavirus – latest updates See all our coronavirus coverage Authorities in Germany and France are under pressure to come up with creative solutions to shift the AstraZeneca vaccine at higher speed in order to avoid a pile-up of unused doses over …

Covid: Germany and France under pressure to shift Oxford vaccine Read More »

Pfizer vaccine may be less effective in people with obesity, says study

Healthcare workers with obesity found to produce only about half the antibodies healthy people do Coronavirus – latest updates See all our coronavirus coverage The Pfizer/BioNTech vaccine may be less effective in people with obesity, data suggests. Italian researchers have discovered that healthcare workers with obesity produced only about half the amount of antibodies in …

Pfizer vaccine may be less effective in people with obesity, says study Read More »

Germany signals AstraZeneca vaccine may be approved for over-65s

Healthcare regulator says it will update recommendations ‘very soon’ in wake of row over jab’s effectiveness in older candidates Coronavirus – latest updates See all our coronavirus coverage Germany could soon authorise the use of the AstraZeneca vaccine for seniors after the head of the country’s vaccination committee said his body’s advice to give the …

Germany signals AstraZeneca vaccine may be approved for over-65s Read More »

AstraZeneca expected to miss EU Covid vaccine supply target by half in second-quarter – report

Expected shortfall of 90m doses could hit the EU’s ability to meet its target of vaccinating 70% of adults by summer Coronavirus – latest updates See all our coronavirus coverage AstraZeneca has told the European Union it expects to deliver less than half the Covid-19 vaccines it was contracted to supply in the second quarter, …

AstraZeneca expected to miss EU Covid vaccine supply target by half in second-quarter – report Read More »

Sussex medicines firm takes production line abroad in white van to beat Brexit ban

UK assembly line at standstill as pharmaceutical company sets up in Amsterdam and plans EU expansion A Sussex pharmaceutical company has told how it had to bundle a production line into a white van and take it to Amsterdam to beat a Brexit medicines ban. The impromptu four-wheeled mission to the Netherlands has secured the …

Sussex medicines firm takes production line abroad in white van to beat Brexit ban Read More »

German politicians counter AstraZeneca vaccine scepticism with show of support

Oxford Covid vaccine described in German media as ‘shelf warmer’ with only 17% of doses administered so far Coronavirus – latest updates See all our coronavirus coverage Politicians in Germany are stepping out in support of the AstraZeneca vaccine as public scepticism around the Oxford-developed product is threatening to hamper Europe’s Covid-19 immunisation programme. The …

German politicians counter AstraZeneca vaccine scepticism with show of support Read More »

Solidarity Is Not an Easy Sell as E.U. Lags in Vaccine Race

Europe’s collective vaccine purchase is an experiment in deeper integration. Despite a rocky start, many countries still stand to benefit, but it’s the most powerful who have least to gain.

Solidarity Is Not an Easy Sell as E.U. Lags in Vaccine Race

Europe’s collective vaccine purchase is an experiment in deeper integration. Despite a rocky start, many countries still stand to benefit, but it’s the most powerful who have least to gain.

Solidarity Is Not an Easy Sell as E.U. Lags in Vaccine Race

Europe’s collective vaccine purchase is an experiment in deeper integration. Despite a rocky start, many countries still stand to benefit, but it’s the most powerful who have least to gain.

France and Germany threaten AstraZeneca over vaccine shortage

Warning of ‘legal commitment’ and concern that doses might have been diverted from the EU to the UK Coronavirus – latest updates See all our coronavirus coverage France and Germany have threatened legal action against the Anglo-Swedish pharmaceutical company AstraZeneca in the row over a shortage of coronavirus vaccine in the EU. Talks between the …

France and Germany threaten AstraZeneca over vaccine shortage Read More »

EU Covid incompetence leaves governments wanting vaccines, not excuses | Larry Elliott

Centralised approach was meant to underline Europe’s solidarity but has had opposite effect The EU has made an almighty hash of procuring treatments for Covid-19. Vaccine centres are running short of supplies as a result. National governments want jabs rather than excuses for what has gone wrong. The search for scapegoats is on. Stripped of …

EU Covid incompetence leaves governments wanting vaccines, not excuses | Larry Elliott Read More »

How EU’s floundering vaccine effort hit a fresh crisis with exports row

A new rule on exports from Europe suddenly blew up into a threat to the withdrawal agreement – and a hasty backtrack Coronavirus – latest updates See all our coronavirus coverage It started with a tweet by a blogger at 4.36pm on Friday. It ended with the prime ministers of the UK and Ireland warning …

How EU’s floundering vaccine effort hit a fresh crisis with exports row Read More »

EU to publish revised rules after Covid vaccine border fiasco

Commission plans to rush through regulations that ‘ensure Northern Ireland protocol remains unaffected’ Coronavirus – latest updates See all our coronavirus coverage Explainer: what is article 16 of the Northern Ireland protocol? Brussels will publish a revised regulation to potentially block vaccine exports out of the EU on Saturday, after an international outcry over its …

EU to publish revised rules after Covid vaccine border fiasco Read More »

What can moral philosophy tell us about the Covid ‘vaccine nationalism’ row? | Alexis Papazoglou

The shortfall in supply has put the EU and the UK at loggerheads, but ethical principles could reveal a solution In normal times, a row between the EU, the UK and a private company over the timely delivery of a contract would be of interest to few apart from the two sides’ lawyers. But these …

What can moral philosophy tell us about the Covid ‘vaccine nationalism’ row? | Alexis Papazoglou Read More »

EU could block millions of Covid vaccine doses from entering UK

European commission says new mechanism will give national regulators power to refuse exports Coronavirus – latest updates See all our coronavirus coverage Millions of doses of vaccines could be blocked from entering Britain from the EU within days, as part of Brussels’ response to a shortage of doses among its member states. The European commission …

EU could block millions of Covid vaccine doses from entering UK Read More »

Patients as Partners Europe: Are we doing patient centricity all wrong?

To be truly patient centric, do we need to turn the current model on its head and work within a more free-thinking, free-speaking framework? Amanda Barrell reports from Patients as Partners Europe. Despite huge progress over the last decade, patient involvement in research is still largely in the hands of the pharmaceutical companies. That is …

Patients as Partners Europe: Are we doing patient centricity all wrong? Read More »

GameStop’s dizzying share price rise means it’s game over for the short-sellers | Nils Pratley

The retailer has gone from $19 to $33o thanks in part to amateurs taking on the hedge funds If you find trading bitcoin insufficiently hair-raising, try GameStop. It is the Texas-based video games retailer that will be hard to out-do as the stock market story of 2021. The share price was $19 at the start …

GameStop’s dizzying share price rise means it’s game over for the short-sellers | Nils Pratley Read More »

The EU’s vaccine bust-up with AstraZeneca is of its own making | Leo Cendrowicz

Slowness to sign up to and approve the vaccine may have caused delays, but Brussels feels the company is being less than cooperative Coronavirus – latest updates See all our coronavirus coverage Last year AstraZeneca was heralded for its pioneering vaccine discovery. Yet today the British-Swedish pharmaceutical company is embroiled in a dispute with the …

The EU’s vaccine bust-up with AstraZeneca is of its own making | Leo Cendrowicz Read More »

AstraZeneca denies pulling out of talks as EU Covid vaccine row deepens

Latest round of crunch talks to discuss breakdown in supplies still happening, says spokesman Coronavirus – latest updates See all our coronavirus coverage A row over coronavirus vaccine shortages in the EU has descended into farce as AstraZeneca denied claims by the European commission that it had pulled out of a crunch meeting over a …

AstraZeneca denies pulling out of talks as EU Covid vaccine row deepens Read More »

Head of AstraZeneca rejects calls for UK vaccine to be diverted to EU

Chief executive of pharmaceutical giant says the firm will honour UK’s earlier contract despite EU anger over shortfall Coronavirus – latest updates See all our coronavirus coverage AstraZeneca’s chief executive has insisted the UK will come first for vaccines as he rejected calls to divert doses to the European Union following a breakdown in supply. …

Head of AstraZeneca rejects calls for UK vaccine to be diverted to EU Read More »

EU means business over Covid vaccine exports, says Von der Leyen

Commission president says firms must deliver on orders after AstraZeneca warns of shortfall Coronavirus – latest updates See all our coronavirus coverage The EU “means business”, Ursula von der Leyen has said, as the bloc doubled down on plans for tighter monitoring of vaccine exports to countries outside of the union, such as the UK. …

EU means business over Covid vaccine exports, says Von der Leyen Read More »

German government challenges AstraZeneca Covid vaccine efficacy reports

Newspaper had reported that government was expecting European regulator’s assessment to show that vaccine was only 8% effective among over-65 The German government has challenged reports of a lower-than-expected efficacy rate of the AstraZeneca vaccine for older people, while reiterating concerns about the British-Swedish pharmaceutical giant’s data reporting. An article in German business daily Handelsblatt …

German government challenges AstraZeneca Covid vaccine efficacy reports Read More »

Germany to administer Covid drugs used to treat Donald Trump

Country will be first in EU to use antibody cocktails after government buys 200,000 doses Specialist clinics in Germany will this week become the first hospitals in the EU to treat Covid-19 patients with expensive and experimental antibody cocktails used to treat the former US president Donald Trump after he caught the virus last October. …

Germany to administer Covid drugs used to treat Donald Trump Read More »

EU’s Covid vaccination debacle is down to institutional inflexibility

Supply delays underline there was no legal or economic justification for central planning A storm is raging over the EU’s failure to have ordered more of the approved Covid-19 vaccines ahead of time. Stéphane Bancel, the CEO of the US pharmaceutical company Moderna, which gained approval for its vaccine shortly after Pfizer/BioNTech, claims that the …

EU’s Covid vaccination debacle is down to institutional inflexibility Read More »

EU plans video summit after doubling supply of Pfizer Covid vaccine

Bloc agrees deal for a further 300m doses as hopes are raised for speedier rate of inoculations Coronavirus – latest updates See all our coronavirus coverage EU leaders are to hold a pandemic video summit on 21 January after the bloc said it had reached a deal with Pfizer and BioNTech for 300m more doses …

EU plans video summit after doubling supply of Pfizer Covid vaccine Read More »

Why cell therapy manufacture is a team sport

Louis van de Wiel, Vice President, Site Head EU Manufacturing, Kite, a Gilead Company, reveals the complexity that sits behind the process of individualised cell therapy – and why team culture makes it work This thought leadership series has been paid and developed by Kite, a Gilead Company. In 2018, we were preparing to build …

Why cell therapy manufacture is a team sport Read More »

BioNTech criticises EU failure to order enough Covid vaccine

Firm races to fill potential gap left by bloc’s gamble on several vaccines being approved Coronavirus – latest updates See all our coronavirus coverage BioNtech has criticised the EU’s failure to order more doses of its coronavirus vaccine, saying it is now racing with its US partner Pfizer to boost production amid fears of a …

BioNTech criticises EU failure to order enough Covid vaccine Read More »

Sector by sector: are British firms ready for post-Brexit trade?

Analysis: From retail to aviation to pharmaceuticals, we look at what will change from 1 January After months of tortuous negotiations between the UK and the EU, a Brexit trade deal was agreed at almost the last minute. But how prepared are UK businesses for the significant changes that will come into force on 1 …

Sector by sector: are British firms ready for post-Brexit trade? Read More »

‘I’ve never seen anything like it’: 2020 smashes records in global markets

From worst crash in a generation to record highs on news of a Covid vaccine, experts review the rollercoaster that was 2020 Coronavirus – latest updates See all our coronavirus coverage 2020 has been the most remarkable year for the global financial markets. After the Covid-19 pandemic triggered the worst crash in a generation, unprecedented …

‘I’ve never seen anything like it’: 2020 smashes records in global markets Read More »

Arsenic in Infant Rice Cereal

When it comes to rice and rice-based products, pediatric nutrition authorities have recommended that arsenic intake should be as low as possible. “The US Food and Drug Administration (FDA) has been monitoring the arsenic content in foods” for decades, yet despite the “well-established science describing the health risks associated with arsenic exposure, no standards have …

Arsenic in Infant Rice Cereal Read More »

Covid vaccine ‘highly likely’ to work on UK variant, BioNTech says

Chief executive, Uğur Şahin, says team will know within two weeks if vaccine works or needs adaption Coronavirus – latest updates See all our coronavirus coverage The chief executive of the German pharmaceutical company BioNTech has said he is confident its coronavirus vaccine works against the new UK variant, but that further studies are need …

Covid vaccine ‘highly likely’ to work on UK variant, BioNTech says Read More »

Belgian minister tweets EU’s Covid vaccine price list to anger of manufacturers

Pharmaceutical companies complain of breach of confidentiality after amount EU has agreed to pay for leading vaccines goes public Coronavirus – latest updates See all our coronavirus coverage A Belgian minister has inadvertently blown the lid off a sensitive and commercial secret – the price that the EU has agreed to pay for the leading …

Belgian minister tweets EU’s Covid vaccine price list to anger of manufacturers Read More »

Kite’s Tecartus (KTE-X19) Receives EC’s Conditional Marketing Authorization for R/R Mantle Cell Lymphoma

Shots: The approval is based on P-II ZUMA-2 study assessing Tecartus in 74 patients with r/r MCL prior treated with anthracycline/ bendamustine-containing CT, an anti-CD20 Ab therapy and a BTK inhibitor (ibrutinib or acalabrutinib) The study demonstrated an OR rate (93 %) with CR (67%), as assessed by an Independent RRC following a single infusion. …

Kite’s Tecartus (KTE-X19) Receives EC’s Conditional Marketing Authorization for R/R Mantle Cell Lymphoma Read More »

Ministers would be wise to play for time before ordering Sizewell C | Nils Pratley

Dashing ahead with a nuclear power station that’s modelled on Hinkley Point C would be reckless This is the government’s problem as it reopens talks on a proposed nuclear power station at Sizewell C in Suffolk: it is contemplating ordering a replica of Hinkley Point C before the Somerset original has produced a single megawatt …

Ministers would be wise to play for time before ordering Sizewell C | Nils Pratley Read More »

Deal or no deal: how life will look for key industries after Brexit

Companies are praying a trade agreement can be struck, but must prepare for talks to fail. Which will be most affected? The scene is set for a showdown, and the future of the UK economy is at stake. Will Britain secure a free trade deal with the EU? Or will the prime minister choose to …

Deal or no deal: how life will look for key industries after Brexit Read More »

Which Brands and Sources of Rice Have the Least Arsenic?

Arsenic levels were tested in 5,800 rice samples from 25 countries.The arsenic found in five servings of rice a week poses a hundred times the acceptable cancer risk. What did the rice industry have to say about that? When the story first broke in the media that U.S. rice had some of the highest arsenic …

Which Brands and Sources of Rice Have the Least Arsenic? Read More »

Kaia Health Allied with Chiesi Group to Commercialize COPD App in Europe

Shots: Kaia Health signs an exclusive agreement with Chiesi Group to commercialize the Kaia Health COPD Pulmonary Rehabilitation app in the EU The app is CE marked in EU as a Class 1 medical device and has been investigated in one pilot trial and is the subject of an ongoing randomized control trial in the …

Kaia Health Allied with Chiesi Group to Commercialize COPD App in Europe Read More »

BioNTech’s Covid vaccine is a triumph of innovation and immigration | Hans-Werner Sinn

Pioneered by a Turkish-German couple, its significance exceeds its practical value The world took note when the German startup BioNTech announced its breakthrough in the development of a new type of vaccine to combat Covid-19. After testing tens of thousands of people, BioNTech’s vaccine has been shown to be 95% effective in providing protection for …

BioNTech’s Covid vaccine is a triumph of innovation and immigration | Hans-Werner Sinn Read More »

Why Was Chicken the Primary Source of Arsenic Exposure in Children?

What was the National Chicken Council’s response to public health authorities calling for the industry to stop feeding arsenic-based drugs to poultry? “Dietary practices influence our exposure to pesticides, toxic heavy metals, persistent organic pollutants, and industrial pollutants….A diet high in fish and other animal products, for example, results in greater exposure to persistent organic compounds …

Why Was Chicken the Primary Source of Arsenic Exposure in Children? Read More »

The calm after the storm: How COVID-19 is making pharma more resilient

COVID-19 is proving to be the perfect storm in terms of the supply of pharmaceutical products. But learning how to overcome the challenges of 2020 will serve the industry well for years to come. As part of our EU Leader series, Christian Pawlu, head of strategy, portfolio and BD&L at Sandoz, told us about how …

The calm after the storm: How COVID-19 is making pharma more resilient Read More »

BioNTech chief rejects Trump claim it delayed Covid vaccine news

Exclusive: Ugur Şahin says he and Pfizer CEO received results night before announcement Coronavirus – latest updates See all our coronavirus coverage The scientist behind the BioNTech/Pfizer coronavirus vaccine has defended his company from Donald Trump’s accusation that it deliberately delayed news of its rapid progress until after the election, saying “we don’t play politics”. …

BioNTech chief rejects Trump claim it delayed Covid vaccine news Read More »

FTSE 100 recovers to highest level since June after vaccine unveiled

Promising clinical data from Pfizer and BioNTech help the index to a £28bn one-day gain Optimism that a mass rollout of Covid-19 vaccines will lead to an economic recovery lifted stocks in London again on Tuesday, to their highest closing level in over four months. London’s FTSE 100 index of blue-chip shares rallied by nearly …

FTSE 100 recovers to highest level since June after vaccine unveiled Read More »

Germany’s digital health changes will boost digital therapeutics in Europe

Digital therapeutics are gaining momentum worldwide and offer developers, including pharma, both a huge opportunity and a stimulating market access challenge, say Olaf Schoeman and Emanuele Arcà. The last 12 months have shone a spotlight on digital transformation in Europe’s healthcare systems, with all the signs pointing to digital therapeutics (DTx) moving ever more into …

Germany’s digital health changes will boost digital therapeutics in Europe Read More »

Pfizer/BioNTech vaccine announcement is cause for cautious celebration

Interim trial results are encouraging as scientists welcome news Coronavirus – latest updates See all our coronavirus coverage It is not yet the end of the pandemic, but the announcement by Pfizer/BioNTech that their vaccine has been 90% successful in the vital large-scale trials has got even the soberest of scientists excited. These are interim …

Pfizer/BioNTech vaccine announcement is cause for cautious celebration Read More »

BioNTech’s Covid vaccine: a shot in the arm for Germany’s Turkish community

Couple who set up and run firm are children of long-maligned ‘guest workers’ from Turkey Coronavirus – latest updates See all our coronavirus coverage When the German biotechnology company BioNTech picked a street called An der Goldgrube or At the Goldmine in the western city of Mainz for its headquarters, the couple behind it could …

BioNTech’s Covid vaccine: a shot in the arm for Germany’s Turkish community Read More »

EMA starts rapid review of Bluebird’s gene therapy for rare disease CALD

Bluebird bio could be just a few months away from approval of its gene therapy for rare disease cerebral adrenoleukodystrophy (CALD) in the EU, after the EMA started an accelerated review. If approved, Lenti-D (elivaldogene autotemcel or eli-cel) could transform the prospects of people with CALD, the most severe form of the neurodegenerative disease ALD …

EMA starts rapid review of Bluebird’s gene therapy for rare disease CALD Read More »

GSK and Sanofi to start human trials of potential Covid-19 vaccine

World’s largest vaccine makers to begin testing on people in US with eye on rollout in early 2021 Coronavirus – latest updates See all our coronavirus coverage GlaxoSmithKline and Sanofi are to start testing their protein-based Covid-19 vaccine on humans for the first time, following promising results in earlier studies. GSK, the world’s largest vaccine …

GSK and Sanofi to start human trials of potential Covid-19 vaccine Read More »

Italian vaccine makers in race to produce flu doses before winter

Authorities order 50% more doses than in 2019 in bid to avoid hospitals being overwhelmed Coronavirus – latest updates See all our coronavirus coverage Italian vaccine manufacturers are scrambling to produce millions of flu vaccination doses amid concern there will not be enough to meet demand this autumn and winter. The country’s 20 regional authorities …

Italian vaccine makers in race to produce flu doses before winter Read More »

Time for a health innovation pact: rethinking the design and delivery of healthcare

Janssen’s Anouk De Vroey on why we need to extend the public/private partnerships resulting from COVID-19 into more high-level dialogue on health innovation with governments. Friday 13th March 2020 – I am not a superstitious person in general, but I will never forget that particular Friday the 13th, as it marked the start of the …

Time for a health innovation pact: rethinking the design and delivery of healthcare Read More »

The Guardian view on Brexit bureaucracy: tied up in red tape | Editorial

Businesses already struggling with the fallout from Covid-19 will be forced to deal with a mountain of new bureaucracy in the middle of a deep recession The government did not quite achieve the Brexit breakthrough it was seeking on Friday, when there was hope that a fast-tracked trade agreement with Japan might be reached. But …

The Guardian view on Brexit bureaucracy: tied up in red tape | Editorial Read More »

Armpit Shaving and Breast Cancer

Shaving before applying underarm antiperspirants can increase aluminum absorption. Could this explain the greater number of tumors and the disproportionate incidence of breast cancer in the upper outer quadrant of the breast near the armpit? A famous case report called “The Mortician’s Mystery,” published in the New England Journal of Medicine back in the 1980s, …

Armpit Shaving and Breast Cancer Read More »

How does HTA for orphan drugs differ across europe?

New research looks at the factors that speed up and slow down HTA appraisals for rare disease medicines across Europe. Rare diseases drugs have always faced challenges when it comes to HTA approvals, even as governments bring in more regulatory policies that make their path through assessment easier. Several factors make it difficult for HTA …

How does HTA for orphan drugs differ across europe? Read More »

UK warns drug firms to stockpile in case of Brexit disruption

Companies should ensure six weeks’ worth of drugs for end of transition period, DHSC says Pharmaceutical companies should stockpile six weeks’ worth of drugs to guard against disruption at the end of the Brexit transition period, the government has said. The Department of Health and Social Care (DHSC) has written to medicine suppliers advising them …

UK warns drug firms to stockpile in case of Brexit disruption Read More »

New digital health player HealthHero launches with Fernarzt buy

There’s a new kid on the block in digital health – called HealthHero – with aspirations to become the biggest company in the European market. The new company officially comes into being today with the acquisition of Berlin-based telemedicine company Fernarzt, which was set up in 2017 and is already offering thousands of online consultations …

New digital health player HealthHero launches with Fernarzt buy Read More »

The Crowding Out Strategy to Eating Healthier

It may be more expedient politically to promote an increase in consumption of healthy items rather than a decrease in consumption of unhealthy items, but it may be far less effective. The World Health Organization has estimated that more than a million deaths “worldwide are linked to low fruit and vegetable consumption.” What can be …

The Crowding Out Strategy to Eating Healthier Read More »

Alnylam’s Anant Murthy on making it as a US biotech in Europe

Alnylam’s European head of market access and GM of mid-size markets, Anant Murthy, shares his perspective on how a US biotech can adapt to the many unique challenges of the EU market. Though they represent the two biggest markets for pharma companies, the EU and US have some stark differences that can often catch out …

Alnylam’s Anant Murthy on making it as a US biotech in Europe Read More »